IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 76-100 out of 1216.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>

Public Release: 22-Jul-2013
Nature Scientific Reports
Health risks from arsenic in rice exposed
High levels of arsenic in rice have been shown to be associated with elevated genetic damage in humans, a new study has found.
UK-India Education Research Initiative, British Council, Indian Institute of Chemical Biology Network Project

Contact: Aeron Haworth
aeron.haworth@manchester.ac.uk
44-161-275-8387
University of Manchester

Public Release: 22-Jul-2013
Pediatric Blood & Cancer
Study highlights female cancer patients unhappy with insufficient fertility support
Young female cancer patients are unhappy about the way fertility preservation options are discussed with them by doctors before starting cancer treatment, according to a new study by researchers from the University of Sheffield and The Children's Hospital, Sheffield.

Contact: Amy Pullan
a.l.pullan@sheffield.ac.uk
01-142-229-859
University of Sheffield

Public Release: 22-Jul-2013
Molecular Cancer Therapeutics
New hope for hormone resistant breast cancer
A new finding provides fresh hope for the millions of women worldwide with oestrogen receptor positive breast cancer. Australian scientists have shown that a specific change, which occurs when tumours become resistant to anti-oestrogen therapy, might make the cancers susceptible to treatment with chemotherapy drugs.

Contact: Alison Heather
a.heather@garvan.org.au
61-292-958-128
Garvan Institute of Medical Research

Public Release: 22-Jul-2013
Immunity
Putting the brakes on inflammation
A team led by a UA researcher has discovered a previously unknown mechanism that prevents the immune system from going into overdrive. The findings shed light on the mechanisms underlying autoimmune disorders such as Crohn's disease, allergies, chronic inflammation and cancer, and offer potential applications for therapies.

Contact: Daniel Stolte
stolte@email.arizona.edu
520-626-4402
University of Arizona

Public Release: 22-Jul-2013
Journal of Clinical Investigation
Protein complex linked to cancer growth may also help fight tumors, Moffitt researchers say
Researchers at Moffitt Cancer Center and Tianjin Medical University Cancer Institute and Hospital in China have discovered a gene expression signature that may lead to new immune therapies for lung cancer patients. They found that NF-κB, a protein complex known to promote tumor growth, may also have the ability to boost the immune system to eliminate cancerous cells before they harm, as well as promote antitumor responses.
NIH/National Cancer Institute

Contact: Kim Polacek
kim.polacek@moffitt.org
813-745-7408
H. Lee Moffitt Cancer Center & Research Institute

Public Release: 22-Jul-2013
82 percent of adults support banning smoking when kids are in the car
A new poll shows 82 percent of adults support banning smoking in cars when children under 13 are riding in the vehicle.

Contact: Mary Masson
mfmasson@umich.edu
734-764-2220
University of Michigan Health System

Public Release: 22-Jul-2013
American Journal of Public Health
University of Hawaii Cancer Center researchers report
University of Hawaii Cancer Center Prevention and Control Program researchers Pallav Pokhrel, Ph.D., and Thaddeus Herzog, Ph.D., have found that smokers who use e-cigarettes as a tool to stop smoking tend to be younger and more motivated to quit smoking as compared to other smokers.

Contact: Bryan Cheplic
bcheplic@cc.hawaii.edu
808-564-5911
University of Hawaii Cancer Center

Public Release: 22-Jul-2013
Annals of Surgical Oncology
Physician bonuses help drive increases in surgery with minimal patient benefit: McMaster study
Financial incentives for Ontario surgeons are likely a key factor driving greater use of laparoscopic colon cancer surgery as few benefits to patients, says McMaster University surgeon in paper published in Annals of Surgical Oncology.
Canadian Institutes for Health Research

Contact: Susan Emigh
emighs@mcmaster.ca
90-552-591-402-2555
McMaster University

Public Release: 22-Jul-2013
Sexually Transmitted Infections
Vaccinating boys plays key role in HPV prevention
Improving vaccination rates against the human papillomavirus (HPV) in boys is key to protecting both men and women, says new research from University of Toronto Professor Peter A. Newman from the Factor-Inwentash Faculty of Social Work. HPV has been linked to anal, penile and certain types of throat cancers in men. Since the virus is also responsible for various cancers in women, vaccinating boys aged 11 to 21 will play a crucial role in reducing cancer rates across the sexes.

Contact: Michael Kennedy
m.kennedy@utoronto.ca
416-946-5025
University of Toronto

Public Release: 22-Jul-2013
BMC Complementary and Alternative Medicine
Integrative medicine interventions found to significantly reduce pain, improve quality of life
An integrative approach to treating chronic pain reduces pain severity while improving mood and quality of life, according to a new study from the Bravewell Practice-Based Research Network published last month in BioMed Central Complementary and Alternative Medicine journal. Researchers found a reduction in pain severity of more than 20 percent and a drop in pain interference of nearly 30 percent in patients after 24 weeks of integrative care.

Contact: Lauren Adams
ladams@gymr.com
202-745-5076
GYMR

Public Release: 21-Jul-2013
Nature Immunology
A first in front line immunity research
Monash University researchers have gained new insight into the early stages of our immune response, providing novel pathways to develop treatments for diseases from multiple sclerosis to cancer.
National Health and Medical Research Council, ARC

Contact: Emily Walker
emily.walker@monash.edu
61-399-034-844
Monash University

Public Release: 19-Jul-2013
eLife
New plan of attack in cancer fight
New research by Harvard scientists shows that, under certain conditions, using two drugs in a "targeted therapy" -- a treatment approach designed to interrupt cancer's ability to grow and spread -- nearly all cancers could be effectively cured.

Contact: Peter Reuell
preuell@fas.harvard.edu
617-496-8070
Harvard University

Public Release: 19-Jul-2013
Psychological Science
If you're not looking for it, you probably won't see it
In a new study from Brigham and Women's Hospital in Boston, researchers have found that even expert searchers, operating in their domain of expertise, are vulnerable to inattentional blindness.

Contact: Jessica Maki
jmaki3@partners.org
617-534-1603
Brigham and Women's Hospital

Public Release: 19-Jul-2013
Nature Cell Biology
Stem cell discovery furthers research on cell-based therapy and cancer
Stem-cell researchers at UC San Francisco have found a key role for a protein called BMI1 that may help scientists direct the development of tissues to replace damaged organs in the human body.
National Institutes of Health, California Institute for Regenerative Medicine

Contact: Jeffrey Norris
jeff.norris@ucsf.edu
415-502-6397
University of California - San Francisco

Public Release: 19-Jul-2013
Proceedings of the National Academy of Sciences
Study finds missing piece of pediatric cancer puzzle
Most of the time, it takes decades of accumulating genetic errors for a tumor to develop. While this explains the general occurrence of cancer in adults, it leaves a gap in understanding of the cause of pediatric tumors.

Contact: Gina Bericchia
gina.bericchia@nationwidechildrens.org
614-355-0495
Nationwide Children's Hospital

Public Release: 18-Jul-2013
American Journal of Public Health
Study finds boys more likely to receive HPV vaccine when their mothers receive preventive care
Boys are more likely to receive the quadrivalent human papillomavirus vaccine if their mothers receive flu shots or Pap screenings, according to a Kaiser Permanente study published in the American Journal of Public Health.
Kaiser Permanente Southern California

Contact: Catherine Hylas Saunders
csaunders@golinharris.com
202-585-2603
Kaiser Permanente

Public Release: 18-Jul-2013
American Journal of Pathology
Ovarian cancer metastases influenced by factors in target tissues
Cancer researchers have wondered why ovarian cancer cells are so attracted to the abdominal cavity, especially the omentum, with the hope that such understanding could lead to better disease management or even prevention. Results from a series of experiments suggest a two-step model of omental colonization in the abdominal cavity in which i) cancer cells are attracted to and lodge within immune cell-containing structures known as milky spots, and ii) fat storage cells (adipocytes) fuel cancer cell growth and spread.

Contact: Eileen Leahy
ajpmedia@elsevier.com
732-238-3628
Elsevier Health Sciences

Public Release: 18-Jul-2013
Annals of Oncology
Moderate dose radiotherapy effective in EORTC trial for patients with desmoid-type fibromatosis
A phase 2 EORTC trial for patients with inoperable desmoid-type fibromatosis has shown that moderate dose radiotherapy is an effective treatment for patients with such a rare type of tumor. The study results published in Annals of Oncology show that response after radiation therapy is slow, and that continuing regression is seen even after three years.
Fonds Cancer

Contact: John Bean
communications@eortc.be
European Organisation for Research and Treatment of Cancer

Public Release: 18-Jul-2013
Science
Thwarting protein production slows cancer cells' malignant march
Protein production or translation is tightly coupled to a highly conserved stress response -- the heat shock response and its primary regulator, heat shock factor 1 (HSF1) -- that cancer cells rely on for survival and proliferation, according to Whitehead Institute researchers. In mouse models of cancer, therapeutic inhibition of translation interrupts HSF1's activity, dramatically slowing tumor growth and potentially rendering drug-resistant tumors responsive to other therapies.
National Institutes of Health, Johnson & Johnson Focused Funding Program, Marble Fund, American Cancer Society New England

Contact: Nicole Rura
rura@wi.mit.edu
617-258-6851
Whitehead Institute for Biomedical Research

Public Release: 18-Jul-2013
American Journal of Physical Medicine & Rehabilitation
Cancer 'prehabilitation' can reduce complications and improve treatment outcomes
For patients with cancer, "prehabilitation" -- interventions given between the time of diagnosis and the start of treatment -- has the potential to reduce complications from treatments and improve physical and mental health outcomes, according to a report in the August American Journal of Physical Medicine & Rehabilitation (AJPM&R). AJPM&R, the official journal of the Association of Academic Physiatrists, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Contact: Connie Hughes
connie.hughes@wolterskluwer.com
646-674-6348
Wolters Kluwer Health

Public Release: 18-Jul-2013
Proceedings of the National Academy of Sciences
Deadliest cancers may respond to new drug treatment strategy
UC San Francisco researchers have found a way to knock down cancers caused by a tumor-driving protein called "myc," paving the way for patients with myc-driven cancers to enroll in clinical trials for experimental treatments. 
National Institutes of Health, Waxman Foundation, Howard Hughes Medical Institute, Truitt

Contact: Jeffrey Norris
jeff.norris@ucsf.edu
415-502-6397
University of California - San Francisco

Public Release: 18-Jul-2013
Nature
RI Hospital: Absence of specific enzyme in cartilage can lead to benign tumors in mice
Rhode Island Hospital researchers have found that the absence of the Shp-2 enzyme near specialized cartilage cells can lead to the development of multiple benign cartilage tumors in mice, a model that recapitulates the rare human tumor syndrome metachondromatosis. Shp2 is an enzyme in the cell that regulates the activity of other proteins and signaling pathways. Mice lacking Shp2 formed two types of tumors: enchondromas and osteochondromas, and also developed deformed joints.
National Institutes of Health, NIH/National Institute for General Medicine Sciences

Contact: Ellen Slingsby
eslingsby@lifespan.org
401-444-6421
Lifespan

Public Release: 17-Jul-2013
2013 ASCO Meeting
TGen-TD2-Scottsdale Healthcare breast cancer pilot study shows value of proteomic mapping
The Side-Out Foundation's breast cancer pilot study, led by the Translational Genomics Research Institute, Translational Drug Development and Scottsdale Healthcare, has shown that cancer patients do better when their treatment is guided by molecular profiling. Specifically, 52 percent of patients with advanced breast cancer received clinical benefit -- meaning their disease was controlled for a longer time -- when their cancer was treated based on addressing the abnormal proteins in their tumor.
Side-Out Foundation

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute

Public Release: 17-Jul-2013
Menopause: The Journal of the North American Menopause Society
Menopause symptoms worse in cancer survivors
Cancer survivors were twice as likely to experience severe menopausal symptoms compared to women who have not had cancer, a new Australian study has found.

Contact: Rebecca Scott
rebeccas@unimelb.edu.au
61-383-440-181
University of Melbourne

Public Release: 17-Jul-2013
Molecular Pharmacology
Compounds outsmart solid tumors' malfunctioning machinery
Molecular biologists in the School of Medicine at The University of Texas Health Science Center San Antonio have found a novel way to fine-tune the activity of cells' protein-disposing machinery, with potentially cancer-fighting effects.
Mike Hogg Foundation, William and Ella Owens Medical Research Foundation

Contact: Will Sansom
sansom@uthscsa.edu
210-567-2579
University of Texas Health Science Center at San Antonio

Showing releases 76-100 out of 1216.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>

  Search News Releases

     

 

 

EurekAlert!